4//SEC Filing
Townson Sharon 4
Accession 0000950170-24-069308
CIK 0001826457other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:10 PM ET
Size
5.4 KB
Accession
0000950170-24-069308
Insider Transaction Report
Form 4
Townson Sharon
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+40,000→ 40,000 totalExercise: $3.98Exp: 2034-06-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001855689
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:10 PM ET
- Size
- 5.4 KB